SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Exelon Corporation (EXCVV) trades at a trailing P/E of 15.1. Trailing earnings yield is 6.62%. PEG 1.28.
Criteria proven by this page:
- VALUE (85/100, Pass) — P/E is below market average (15.1); earnings yield beats bond yields (6.62%).
- PEG Ratio 1.28 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 6.62% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 56/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
85/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — EXCVV
Valuation Multiples
P/E (TTM)15.1
Forward P/EN/A
PEG Ratio1.28
Forward PEGN/A
P/B Ratio0.00
P/S Ratio1.73
EV/EBITDA0.0
Per Share Data
EPS (TTM)$2.74
Book Value / Share$0.00
Revenue / Share$23.97
FCF / Share$0.00
Yields & Fair Value
Earnings Yield6.62%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.22 |
$31.36B |
$1.13B |
3.6% |
| 2017 |
$3.97 |
$33.53B |
$3.77B |
11.2% |
| 2018 |
$2.07 |
$35.99B |
$2.01B |
5.6% |
| 2019 |
$3.01 |
$34.44B |
$2.94B |
8.5% |
| 2020 |
$2.01 |
$33.04B |
$1.96B |
5.9% |
| 2021 |
$1.74 |
$17.94B |
$1.71B |
9.5% |
| 2022 |
$2.20 |
$19.08B |
$2.17B |
11.4% |
| 2023 |
$2.34 |
$21.73B |
$2.33B |
10.7% |
| 2024 |
$2.45 |
$23.03B |
$2.46B |
10.7% |
| 2025 |
$2.74 |
$24.26B |
$2.77B |
11.4% |
